Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.12.02.626446Source: DataRank Database

A TROP2/Claudin Program Mediates Immune Exclusion to Impede Checkpoint Blockade in Breast Cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0.269. It has been cited 5 times.

N/A

0.269DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (26)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.269

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (22)

Win Thant,Elena Bitman,Ting Liu ORCID,Jie Liu ORCID,Eleftherios I. Paschalis ORCID

Live enrichment

PubMed:39677819 OpenAlex:https://openalex.org/W4405040296

National Cancer Institute

Grant: K99CA286969

National Cancer Institute

Grant: R00CA286969

National Cancer Institute

Grant: R01CA260890

United States Department of Defense

Grant: BC200924

United States Department of Defense

Grant: BC240454

greenLicense: cc-by-nc

repositoryhttps://doi.org/10.1101/2024.12.02.626446

publisherhttps://syndication.highwire.org/content/doi/10.1101/2024.12.02.626446

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39677819

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11642930

Fields of Study

Barrier Structure and Function StudiesSingle-cell and spatial transcriptomicsCancer Immunotherapy and Biomarkers

Keywords

ImmunotherapyCancer researchImmune systemCancer immunotherapyBlockadeImmune checkpointT cellCancerBreast cancerMedicineImmunologyReceptorInternal medicineAntibody-Drug ConjugatePD-1TROP2antitumor immunityimmune checkpoint blockadeimmune exclusionsacituzumab govitecantight junctiontriple negative breast cancertumor immune microenvironment

Sustainable Development Goals

SDG 0: Reduced inequalities